DNA methylation profiling in breast cancer discordant identical twins identifies DOK7 as novel epigenetic biomarker

Carcinogenesis

Volumn 34, Issue 1, 2013, Pages 102-108

  Heyn, Holger ^a   Carmona Javier, F ^a   Gomez, Antonio ^a   Ferreira, Humberto J ^a,b   Bell, Jordana T ^c   Sayols, Sergi ^a   Ward, Kirsten ^c   Stefansson, Olafur A ^a   Moran, Sebastian ^a   Sandoval, Juan ^a   Eyfjord, Jorunn E ^d,e   Spector, Tim D ^c   Esteller, Manel ^a,f,g  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d ICELANDIC CANCER SOCIETY   (Iceland)

^e UNIVERSITY OF ICELAND   (Iceland)

^f UNIVERSITY OF BARCELONA   (Spain)

^g INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DOCKING PROTEIN; PROTEIN DOK7; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; COHORT ANALYSIS; CPG ISLAND; DNA EXTRACTION; DNA FINGERPRINTING; DNA METHYLATION; EPIGENETICS; HUMAN; HUMAN TISSUE; MONOZYGOTIC TWINS; PATHOGENESIS; PRIORITY JOURNAL;

BIOLOGICAL MARKERS; BREAST NEOPLASMS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; HUMANS; MUSCLE PROTEINS; TWIN STUDIES AS TOPIC;

EID: 84872132897     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs321     Document Type: Article

References (41)

1. Esteller, M. et al. (2000) Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J. Natl. Cancer Inst., 92, 564-569.
2. Stefansson, O.A. et al. (2011) CpG island hypermethylation of BRCA1 and loss of pRb as co-occurring events in basal/triple-negative breast cancer. Epigenetics, 6, 638-649.
3. Birgisdottir, V. et al. (2006) Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer. Breast Cancer Res., 8, R38.
4. Fong, P.C. et al. (2009) Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N. Engl. J. Med., 361, 123-134.
5. Veeck, J. et al. (2010) BRCA1 CpG island hypermethylation predicts sensitivity to poly(adenosine diphosphate)-ribose polymerase inhibitors. J. Clin. Oncol., 28, e563-4; author reply e565.
6. Silver, D.P. et al. (2010) Efficacy of neoadjuvant cisplatin in triple-negative breast cancer. J. Clin. Oncol., 28, 1145-1153.
7. Esteller, M. (2007) Cancer epigenomics: DNA methylomes and histonemodification maps. Nat. Rev. Genet., 8, 286-298.
8. Hon, G.C. et al. (2012) Global DNA hypomethylation coupled to repressive chromatin domain formation and gene silencing in breast cancer. Genome Res., 22, 246-258.
9. Esteller, M. (2008) Epigenetics in cancer. N. Engl. J. Med., 358, 1148-1159.
10. Bell, J.T. et al. (2011) DNA methylation patterns associate with genetic and gene expression variation in HapMap cell lines. Genome Biol., 12, R10.
11. Bell, J.T. et al. (2012) Epigenome-wide scans identify differentially methylated regions for age and age-related phenotypes in a healthy ageing population. PLoS Genetics, 8, e1002629.
12. Bell, J.T. et al. (2011) A twin approach to unraveling epigenetics. Trends Genet., 27, 116-125.
13. Sandoval, J. et al. (2011) Validation of a DNA methylation microarray for 450, 000 CpG sites in the human genome. Epigenetics, 6, 692-702.
14. Bibikova, M. et al. (2011) High density DNA methylation array with single CpG site resolution. Genomics, 98, 288-295.
15. Rakyan, V.K. et al. (2011) Identification of type 1 diabetes-associated DNA methylation variable positions that precede disease diagnosis. PLoS Genet., 7, e1002300.
16. Javierre, B.M. et al. (2010) Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome Res., 20, 170-179.
17. Benjamini, Y. et al. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Statist Soc. B, 57, 289-300.
18. Hall, M.A. (1999) Correlation-Based Feature Subset Selection for Machine Learning. Ph.D. Thesis, Department of Computer Science, Waikato University, Waikato, New Zealand.
19. Warde-Farley, D. et al. (2010) The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res., 38, W214-W220.
20. Bindea, G. et al. (2009) ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics, 25, 1091-1093.
21. Irizarry, R.A. et al. (2009) The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat. Genet., 41, 178-186.
22. Doi, A. et al. (2009) Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat. Genet., 41, 1350-1353.
23. Hunter, D.J. et al. (2007) A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat. Genet., 39, 870-874.
24. Futreal, P.A. et al. (2004) A census of human cancer genes. Nat. Rev. Cancer, 4, 177-183
25. Ito, Y. et al. (2008) Somatically acquired hypomethylation of IGF2 in breast and colorectal cancer. Hum. Mol. Genet., 17, 2633-2643.
26. Korshunova, Y. et al. (2008) Massively parallel bisulphite pyrosequencing reveals the molecular complexity of breast cancer-associated cytosinemethylation patterns obtained from tissue and serum DNA. Genome Res., 18, 19-29.
27. Brennan, K. et al.; KConFab Investigators. (2012) Intragenic ATM methylation in peripheral blood DNA as a biomarker of breast cancer risk. Cancer Res., 72, 2304-2313.
28. Lister, R. et al. (2011) Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature, 471, 68-73.
29. Doi, A. et al. (2009) Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nature Genet., 41, 1350-1353.
30. Smith, Z.D. et al. (2012) A unique regulatory phase of DNA methylation in the early mammalian embryo. Nature, 484, 339-344.
31. Campan, M. et al. (2011) Genome-scale screen for DNA methylation-based detection markers for ovarian cancer. PLoS ONE, 6, e28141.
32. Fernandez, A.F. et al. (2012) A DNA methylation fingerprint of 1628 human samples. Genome Res., 22, 407-419.
33. Hansen, K.D. et al. (2011) Increased methylation variation in epigenetic domains across cancer types. Nat. Genet., 43, 768-775.
34. Hanahan, D. et al. (2000) The hallmarks of cancer. Cell, 100, 57-70.
35. Molaro, A. et al. (2011) Sperm methylation profiles reveal features of epigenetic inheritance and evolution in primates. Cell, 146, 1029-1041.
36. Hodges, E. et al. (2011) Directional DNA methylation changes and complex intermediate states accompany lineage specificity in the adult hematopoietic compartment. Mol. Cell, 44, 17-28.
37. Bergamin, E. et al. (2010) The cytoplasmic adaptor protein Dok7 activates the receptor tyrosine kinase MuSK via dimerization. Mol. Cell, 39, 100-109.
38. Ebert, M.S. et al. (2010) Emerging roles for natural microRNA sponges. Curr. Biol., 20, R858-R861.
39. Kim, S.J. et al. (2011) Development of microRNA-145 for therapeutic application in breast cancer. J. Control. Release, 155, 427-434.
40. Sachdeva, M. et al. (2010) MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. Cancer Res., 70, 378-387.
41. Iorio, M.V. et al. (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res., 65, 7065-7070.